Dr. Bradley Whitman MD

Recommended Articles

• New Multiple Sclerosis Treatment, Ocrevus, Slows Down Disease Progression

  In 2017, the United States Food and Drug Administration (USFDA) approved the drug – Ocrevus (ocrelizumab) – as a treatment for both relapsing and progressive forms of multiple sclerosis. ...

• What Is Lumosity?

  Introduction Lumosity is basically an online brain-training program, which consists of games to help in the improvement of flexibility, memory, attention span, the speed of processing information, quick problem-solving, and decision-making techniques. Lumos Labs was founded in the year 2005 by David...

• What Is Hemicrania Continua?

  IntroductionHemicrania continua is a rare and severe form of daily headaches. It is a continuous headache disorder, which is known to affect more women than men. It is a primary headache disorder, which means that an underlying cause has already been ruled out by carefully examining the medical...

• Fighting Alzheimer’s by Flying Around the World

  Dr. Ed Galkin, 82, wants to find a cure for Alzheimer’s disease. His older brother died from compilations of Alzheimer’s two years ago, and Dr. Galkin does not want to see this happen for others. ...

• Multiple Sclerosis: How it Feels to Live with a Progressive Disease

  When spring kicks in, you might be hyper-aware now of everything you've done, good and bad, since last year at this time.  Maybe you're mulling over what you haven't achieved, or the weight you didn't lose that you promised as a New Years's resolution. Instead of being happy, you are sad with a...

• As Multiple Sclerosis Urgency Increases, Prices Are Projected to Rise

  Access to affordable health care has been a fundamental question for all developed nations, and remains particularly relevant to the United States today. It is crucial that patients with chronic or life-threatening illnesses have continuous access to quality health care, and that the cost of that...